Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Severe Coronavirus Disease 2019)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT05387278
What this trial is testing

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeRespiratory Distress Syndrome
Vitti Labs, LLC 20
Not applicableActive Not RecruitingNCT05467917
What this trial is testing

ARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases

Who this might be right for
COVID-19HouseholdsSARS CoV 2 Infection
Columbia University 374
Large-scale testing (Phase 3)Ended earlyNCT04695704
What this trial is testing

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

Who this might be right for
Covid19SARS (Disease)
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 86
Large-scale testing (Phase 3)Study completedNCT04494984
What this trial is testing

Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Who this might be right for
COVID-19
Inmunova S.A. 243
Not applicableLooking for participantsNCT04582903
What this trial is testing

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

Who this might be right for
COVID-19 Infection
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Large-scale testing (Phase 3)Study completedNCT04467840
What this trial is testing

Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia

Who this might be right for
COVID-19Lung Infection
RedHill Biopharma Limited 475
Not applicableStudy completedNCT04610554
What this trial is testing

Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19

Who this might be right for
COVID-19 Pneumonia
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 74
Large-scale testing (Phase 3)Study completedNCT04397562
What this trial is testing

A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19

Who this might be right for
COVID-19
Biocad 206
Large-scale testing (Phase 3)WithdrawnNCT04575064
What this trial is testing

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Who this might be right for
SARS-CoV-2 InfectionCOVID-19Moderate and Severe COVID-19
Professor Dr. Bernd Mühlbauer
Testing effectiveness (Phase 2)UnknownNCT04299152
What this trial is testing

Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome (SARS) Pneumonia
Throne Biotechnologies Inc. 20
Large-scale testing (Phase 3)Study completedNCT04304053
What this trial is testing

Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention

Who this might be right for
COVID-19
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 2,300
Not applicableStudy completedNCT04490200
What this trial is testing

Effectiveness of a Novel Respirator With Chitosan Nanoparticles

Who this might be right for
Covid19SARS-CoV InfectionWorker-Patient Transmission, Healthcare
University of Brasilia 300
Testing effectiveness (Phase 2)Study completedNCT04710199
What this trial is testing

Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Virus Diseases
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 44
Large-scale testing (Phase 3)Study completedNCT04510493
What this trial is testing

Canakinumab in Patients With COVID-19 and Type 2 Diabetes

Who this might be right for
Coronavirus InfectionDiabetes Mellitus, Type 2
University Hospital, Basel, Switzerland 116
Large-scale testing (Phase 3)Study completedNCT04346693
What this trial is testing

An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19

Who this might be right for
Acute Respiratory Tract InfectionAcute Respiratory InsufficiencyPneumonia+2 more
Burnasyan Federal Medical Biophysical Center 320
Not applicableStudy completedNCT04583319
What this trial is testing

Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection

Who this might be right for
SARS-CoV
Firalis SA 300
Not applicableStudy completedNCT05650944
What this trial is testing

How Important Are Hematological Parameters in the Prognosis of Severe Covid-19 Patients?

Who this might be right for
COVID-19
Hisar Intercontinental Hospital 125
Early research (Phase 1)Looking for participantsNCT07445971
What this trial is testing

A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.

Who this might be right for
COVID -19COVID-19 (Prevention)
ModeX Therapeutics, An OPKO Health Company 80
Large-scale testing (Phase 3)UnknownNCT04780152
What this trial is testing

TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic

Who this might be right for
Major Depressive Disorder
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez 172
Not applicableStudy completedNCT04885452
What this trial is testing

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

Who this might be right for
SARS-CoV InfectionCovid19
ANRS, Emerging Infectious Diseases 756
Next Page